转录因子MAFF调控连接炎症与胆固醇代谢的动脉粥样硬化相关网络
本研究基于小鼠和人类动脉粥样硬化相关基因构建肝脏基因调控网络,识别出转录因子MAFF为关键驱动因子。MAFF与LDLR表达在非炎症条件下正相关,而在脂多糖刺激的炎症条件下负相关,且BACH1协助MAFF异二聚体结合LDLR启动子下调其表达。MAFF可能是连接炎症、脂质代谢与冠心病的潜在治疗靶点。
要点
- MAFF是肝脏动脉粥样硬化相关网络的关键转录因子,与LDLR表达相关。
- 炎症刺激下MAFF与BACH1形成异二聚体下调LDLR表达。
- MAFF可能成为连接炎症与胆固醇代谢的冠心病治疗靶点。
核心结论
- MAFF被鉴定为动脉粥样硬化/冠心病相关肝脏网络的新型核心调控因子。
- MAFF触发LDLR及其他已知影响冠心病风险基因的背景特异性表达。
- 结果提示MAFF是炎症、脂质和脂蛋白代谢之间的缺失环节及潜在治疗靶点。
研究设计与样本
- 基于数百个小鼠敲除模型和人类全基因组关联研究已知的动脉粥样硬化风险基因,构建肝脏基因调控网络。
- 网络层级顺序和调控方向基于贝叶斯预测模型以及染色质免疫沉淀DNA测序、染色质免疫沉淀质谱、过表达、小干扰RNA敲低和小鼠敲除实验。
- 在600例接受搭桥手术的冠心病患者(STARNET)和涉及105个不同近交小鼠品系的杂交小鼠多样性面板中分析基因表达相关性。
主要发现
- MAFF作为关键驱动因子与3个位于冠心病GWAS位点的人类基因和11个动脉粥样硬化小鼠基因相互作用。
- 在600例接受搭桥手术的冠心病患者和105个不同近交小鼠品系的杂交小鼠多样性面板中,LDLR基因表达水平与MAFF相关。
- 非炎症条件下,体外和体内均显示MAFF与LDLR正相关;脂多糖刺激后,体外和体内观察到MAFF与LDLR负相关。
- 染色质免疫沉淀质谱显示,在脂多糖刺激下,人类冠心病GWAS候选基因BACH1协助MAFF,各自异二聚体结合于LDLR启动子的MAF识别元件,转录下调LDLR表达。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Coronary artery disease (CAD) is a multifactorial condition with both genetic and exogenous causes. The contribution of tissue-specific functional networks to the development of atherosclerosis remains largely unclear. The aim of this study was to identify and characterize central regulators and networks leading to atherosclerosis. METHODS: Based on several hundred genes known to affect atherosclerosis risk in mouse (as demonstrated in knockout models) and human (as shown by genome-wide association studies), liver gene regulatory networks were modeled. The hierarchical order and regulatory directions of genes within the network were based on Bayesian prediction models, as well as experimental studies including chromatin immunoprecipitation DNA-sequencing, chromatin immunoprecipitation mass spectrometry, overexpression, small interfering RNA knockdown in mouse and human liver cells, and knockout mouse experiments. Bioinformatics and correlation analyses were used to clarify associations between central genes and CAD phenotypes in both human and mouse. RESULTS: The transcription factor MAFF (MAF basic leucine zipper transcription factor F) interacted as a key driver of a liver network with 3 human genes at CAD genome-wide association studies loci and 11 atherosclerotic murine genes. Most importantly, expression levels of the low-density lipoprotein receptor (LDLR) gene correlated with MAFF in 600 CAD patients undergoing bypass surgery (STARNET [Stockholm-Tartu Atherosclerosis Reverse Network Engineering Task]) and a hybrid mouse diversity panel involving 105 different inbred mouse strains. Molecular mechanisms of MAFF were tested in noninflammatory conditions and showed positive correlation between MAFF and LDLR in vitro and in vivo. Interestingly, after lipopolysaccharide stimulation (inflammatory conditions), an inverse correlation between MAFF and LDLR in vitro and in vivo was observed. Chromatin immunoprecipitation mass spectrometry revealed that the human CAD genome-wide association studies candidate BACH1 (BTB domain and CNC homolog 1) assists MAFF in the presence of lipopolysaccharide stimulation with respective heterodimers binding at the MAF recognition element of the LDLR promoter to transcriptionally downregulate LDLR expression. CONCLUSIONS: The transcription factor MAFF was identified as a novel central regulator of an atherosclerosis/CAD-relevant liver network. MAFF triggered context-specific expression of LDLR and other genes known to affect CAD risk. Our results suggest that MAFF is a missing link between inflammation, lipid and lipoprotein metabolism, and a possible treatment target.
引用
- von Scheidt M, Zhao Y, de Aguiar Vallim TQ, et al. Transcription Factor MAFF (MAF Basic Leucine Zipper Transcription Factor F) Regulates an Atherosclerosis Relevant Network Connecting Inflammation and Cholesterol Metabolism. Circulation. 2021. PMID: 33626882. doi:10.1161/CIRCULATIONAHA.120.050186
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。